Molecular cytogenetics of lymphoma: where do we stand in 2010?

Philip Kluin*, Ed Schuuring

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

23 Citaten (Scopus)


For the past 20 years most malignant lymphomas have been classified as clinicopathological entities, each with its own combination of clinical, morphological, immunophenotypic and molecular genetic characteristics. Molecular and cytogenetic abnormalities can be detected by a wide range of techniques, ranging from conventional karyotyping to single nucleotide polymorphism analysis. In this review, we consider the common genetic abnormalities found in lymphoma and discuss the advantages and disadvantages of individual techniques used in their detection. Finally, we discuss briefly possible novel developments in the field of lymphoma diagnostics.

Originele taal-2English
Pagina's (van-tot)128-144
Aantal pagina's17
Nummer van het tijdschrift1
StatusPublished - jan-2011

Citeer dit